Nisa Investment Advisors Portfolio holdings
AUM
$22.2B
1-Year Return
21.03%
This Quarter Return
+5.94%
1 Year Return
+21.03%
3 Year Return
+95.61%
5 Year Return
+159.15%
10 Year Return
+382.87%
AUM
$8.42B
AUM Growth
+$185M
(+2.2%)
Cap. Flow
-$210M
Cap. Flow
% of AUM
-2.5%
Top 10 Holdings %
Top 10 Hldgs %
15.06%
Holding
1,960
New
82
Increased
359
Reduced
1,036
Closed
89
Top Buys
| 1 |
Vanguard Long-Term Corporate Bond ETF
VCLT
|
+$20.3M |
| 2 |
Abbott
ABT
|
+$7.66M |
| 3 |
Procter & Gamble
PG
|
+$5.32M |
| 4 |
AT&T
T
|
+$4.72M |
| 5 |
Crown Castle
CCI
|
+$3.79M |
Top Sells
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$8.32M |
| 2 |
STJ
St Jude Medical
STJ
|
+$7.33M |
| 3 |
CME Group
CME
|
+$5.34M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$4.38M |
| 5 |
Apple
AAPL
|
+$2.98M |
Sector Composition
| 1 | Financials | 15.36% |
| 2 | Technology | 15.22% |
| 3 | Healthcare | 13.39% |
| 4 | Industrials | 10.79% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Lithia Motors
LAD
$8.84B
| $9K | ﹤0.01% |
110
-90
| -45% | -$7.36K |
|
1702
Lexicon Pharmaceuticals
LXRX
$411M
| $9K | ﹤0.01% |
640
-560
| -47% | -$7.88K |
|
1703
Magnite
MGNI
$3.47B
| $9K | ﹤0.01% |
+1,600
| New | +$9K |
|
1704
Marten Transport
MRTN
$948M
| $9K | ﹤0.01% |
925
-825
| -47% | -$8.03K |
|
1705
MaxLinear
MXL
$1.4B
| $9K | ﹤0.01% |
320
-280
| -47% | -$7.88K |
|
1706
National CineMedia
NCMI
$436M
| $9K | ﹤0.01% |
69
-61
| -47% | -$7.96K |
|
1707
Phibro Animal Health
PAHC
$1.67B
| $9K | ﹤0.01% |
320
-280
| -47% | -$7.88K |
|
1708
Pegasystems
PEGA
$9.75B
| $9K | ﹤0.01% |
400
-1,200
| -75% | -$27K |
|
1709
Rush Enterprises Class A
RUSHA
$4.48B
| $9K | ﹤0.01% |
608
-517
| -46% | -$7.65K |
|
1710
Saia
SAIA
$8.16B
| $9K | ﹤0.01% |
210
-190
| -48% | -$8.14K |
|
1711
Steelcase
SCS
$1.94B
| $9K | ﹤0.01% |
530
-470
| -47% | -$7.98K |
|
1712
SPS Commerce
SPSC
$4.21B
| $9K | ﹤0.01% |
320
-280
| -47% | -$7.88K |
|
1713
Sarepta Therapeutics
SRPT
$1.85B
| $9K | ﹤0.01% |
320
-280
| -47% | -$7.88K |
|
1714
Alaunos Therapeutics
TCRT
$5.07M
| $9K | ﹤0.01% |
10
-9
| -47% | -$8.1K |
|
1715
UBS Group
UBS
$127B
| $9K | ﹤0.01% |
560
| – | – |
|
|
TVRD
1716
Tvardi Therapeutics, Inc. Common Stock
TVRD
$298M
| $9K | ﹤0.01% |
+14
| New | +$9K |
|
|
MANT
1717
DELISTED
Mantech International Corp
MANT
| $9K | ﹤0.01% |
270
-230
| -46% | -$7.67K |
|
|
IMPV
1718
DELISTED
Imperva, Inc.
IMPV
| $9K | ﹤0.01% |
210
-190
| -48% | -$8.14K |
|
|
GNBC
1719
DELISTED
Green Bancorp, Inc
GNBC
| $9K | ﹤0.01% |
530
-470
| -47% | -$7.98K |
|
|
CPLA
1720
DELISTED
Capella Education Company
CPLA
| $9K | ﹤0.01% |
110
-90
| -45% | -$7.36K |
|
|
SPNC
1721
DELISTED
Spectranetics Corp
SPNC
| $9K | ﹤0.01% |
320
-280
| -47% | -$7.88K |
|
|
DGI
1722
DELISTED
DigitalGlobe Inc.
DGI
| $9K | ﹤0.01% |
270
-230
| -46% | -$7.67K |
|
1723
Axon Enterprise
AXON
$57.5B
| $8K | ﹤0.01% |
370
-330
| -47% | -$7.14K |
|
1724
BioCryst Pharmaceuticals
BCRX
$1.7B
| $8K | ﹤0.01% |
+1,000
| New | +$8K |
|
1725
Builders FirstSource
BLDR
$15.5B
| $8K | ﹤0.01% |
530
-470
| -47% | -$7.09K |
|